ghk cu peptide injection sites GHK-Cu Injection: Clinical Considerations – PlexusDx GHK‑Cu Copper Peptide Therapy |
Description
This group of corrinoids is also known as cobalamins

This synthetic phosphopeptide reached Phase III clinical trials, making it one of the few peptide-based therapies to advance that far in autoimmune disease research
10.1016/j.neuron.2011.05.012 Neuron 91 SahayA.ScobieK

At this concentration, a 1 mg dose equals 0.50 mL (50 units), which is easy to measure precisely

Your provider will perform a thorough evaluation to determine if peptide therapy is right for you, and will work with you to develop a customized treatment plan

(3) Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO
